Coherus to Participate in Upcoming Investor Conferences

What happened

Coherus Oncology announced it will webcast its participation in the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on November 10, 2026, and the Jefferies Global Healthcare Conference in London on November 16, 2026. Replays will remain available for 30 days.

Confirmed

Global impact / market context

Investor conference presentations give company management a public setting to discuss strategy and the LOQTORZI sales effort. Webcasts and replays let a wider group of investors hear those comments, which can shape how they judge the company's commercial progress and pipeline.

Analyst inference

Coherus describes itself as a commercial-stage oncology company selling an approved PD-1 inhibitor, a type of cancer immunotherapy, while developing two mid-stage candidates. For such companies, investor attention often centers on sales growth and on how far clinical programs have advanced.

Analyst inference

What to watch

1. The Guggenheim conference webcast is scheduled for November 10, 2026, at 7:30 a.m. Eastern Daylight Time, and the Jefferies conference webcast for November 16, 2026. Confirmed
2. Investors can request one-on-one meetings with company management during the conferences by contacting their respective bank representative, as stated in the announcement. Proposed
3. Listen for updates on LOQTORZI sales in nasopharyngeal carcinoma, a head and neck cancer, because growing those sales is described as the company's strategy and could affect revenue. Analyst inference

Evidence

• globenewswire.com